Ian Clements
Corporate Officer/Principal bei National Investor Relations Institute
Vermögen: 734 969 $ am 30.04.2024
Profil
Ian Clements is a professional with experience in various firms.
He is currently a member of The Royal Society of Chemistry and the National Investor Relations Institute.
He has previously worked as Director-Marketing Communications at BIOVIA, Inc., Senior Director-Corporate Communications at Sequenom, Inc., Head-Investor Relations & Corporate Communications at Avanir Pharmaceuticals, Inc., VP-Investor Relations & Corporate Communications at Tobira Therapeutics, Inc., and Vice President-Investor Relations at Dermira, Inc. Currently, he is serving as the Chief Financial Officer at Mirum Pharmaceuticals, Inc. Dr. Clements holds a doctorate from The University of Manchester, an undergraduate degree from Staffordshire University, and an MBA from The Open University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
10.11.2022 | 30 011 ( 0,06% ) | 734 969 $ | 30.04.2024 |
Aktive Positionen von Ian Clements
Unternehmen | Position | Beginn |
---|---|---|
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ian Clements
Unternehmen | Position | Ende |
---|---|---|
MIRUM PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 15.05.2023 |
DERMIRA, INC. | Investor Relations Kontakt | 01.03.2019 |
TOBIRA THERAPEUTICS INC | Investor Relations Kontakt | 01.12.2016 |
AVANIR PHARMACEUTICALS INC | Investor Relations Kontakt | 01.06.2015 |
ACCELRYS, INC. | Vertrieb & Marketing | - |
Ausbildung von Ian Clements
Staffordshire University | Undergraduate Degree |
The University of Manchester | Doctorate Degree |
The Open University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
BIOVIA, Inc.
BIOVIA, Inc. Packaged SoftwareTechnology Services BIOVIA, Inc. develops and commercializes scientific informatics software products and services for industries and organizations that rely on scientific innovation. Its enterprise platform provides a broad, flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. The company by incorporating its capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, it enables scientific innovators to access, organize, analyze and share data in various ways. BIOVIA was founded in 1993 and is headquartered in San Diego, CA. | Technology Services |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Commercial Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |